• 1. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 2. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 3. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587

4-(2,3-Difluorophenyl)-2-nitrobenzoic Acid: A Comprehensive Guide to Properties and Applications

4-(2,3-Difluorophenyl)-2-nitrobenzoic acid (CAS No. 1261921-79-2) is a specialized fluorinated nitrobenzoic acid derivative that has gained significant attention in pharmaceutical and material science research. This compound, characterized by its unique difluorophenyl and nitrobenzoic acid structure, serves as a valuable intermediate in organic synthesis. Researchers are particularly interested in its potential for creating novel drug candidates and advanced materials, especially in the development of targeted therapies and bioactive molecules.

The molecular structure of 4-(2,3-Difluorophenyl)-2-nitrobenzoic acid features two distinct functional groups: the electron-withdrawing nitro group at the 2-position and the difluorophenyl moiety at the 4-position. This combination creates interesting electronic properties that make it useful for structure-activity relationship (SAR) studies in medicinal chemistry. The presence of fluorine atoms enhances the compound's metabolic stability and membrane permeability, key factors in pharmacokinetic optimization of potential drug molecules.

Recent studies highlight the growing importance of fluorinated aromatic compounds like 4-(2,3-Difluorophenyl)-2-nitrobenzoic acid in addressing current challenges in drug discovery. With approximately 30% of newly approved drugs containing fluorine atoms, this compound aligns with the pharmaceutical industry's focus on fluorine-containing bioactive molecules. Its applications extend to the development of enzyme inhibitors, particularly for targets involved in inflammatory and metabolic disorders, making it relevant to current research on personalized medicine approaches.

The synthesis of 4-(2,3-Difluorophenyl)-2-nitrobenzoic acid typically involves multi-step organic reactions, with careful control of reaction conditions to ensure high purity. Advanced analytical techniques such as HPLC, NMR spectroscopy, and mass spectrometry are employed for characterization and quality control. These rigorous protocols ensure the compound meets the standards required for pharmaceutical research and material science applications, where even minor impurities can significantly impact experimental outcomes.

In material science, the 4-(2,3-Difluorophenyl)-2-nitrobenzoic acid structure offers interesting possibilities for creating functional materials with specific electronic properties. Researchers are exploring its potential in designing organic semiconductors and liquid crystal materials, particularly for applications in optoelectronic devices. The compound's ability to influence molecular packing and charge transport makes it valuable for developing next-generation display technologies and organic electronic components.

The market for fluorinated pharmaceutical intermediates like 4-(2,3-Difluorophenyl)-2-nitrobenzoic acid has shown steady growth, driven by increasing demand for targeted drug therapies and specialty chemicals. Manufacturers focus on developing scalable synthesis methods while maintaining strict quality standards. Current trends emphasize green chemistry approaches to reduce environmental impact, including solvent optimization and catalytic methods, reflecting the industry's commitment to sustainable chemical production.

Storage and handling of 4-(2,3-Difluorophenyl)-2-nitrobenzoic acid require standard laboratory precautions for organic compounds. It should be kept in a cool, dry environment, protected from light and moisture to maintain stability. While not classified as hazardous under normal handling conditions, proper personal protective equipment should be used when working with this chemical, following established laboratory safety protocols for organic synthesis intermediates.

Future research directions for 4-(2,3-Difluorophenyl)-2-nitrobenzoic acid include exploring its potential in covalent organic frameworks (COFs) and as a building block for metal-organic frameworks (MOFs). These applications leverage its structural features to create materials with tailored porosity and functionality. Additionally, its role in developing PET imaging probes and theranostic agents represents an exciting frontier in medical imaging and precision medicine, addressing current needs in diagnostic technology development.

For researchers sourcing 4-(2,3-Difluorophenyl)-2-nitrobenzoic acid, it's important to verify the supplier's quality certifications and analytical data. Reputable suppliers provide comprehensive characterization data including chromatographic purity, spectroscopic confirmation, and batch-to-batch consistency information. These quality indicators are crucial for ensuring reproducible results in sensitive applications like medicinal chemistry and materials research.

The scientific literature contains numerous references to difluorophenyl-containing compounds and their applications, with 4-(2,3-Difluorophenyl)-2-nitrobenzoic acid representing an important example of this structural class. Recent publications highlight its use in developing kinase inhibitors and GPCR modulators, reflecting current interests in signal transduction targeting. These applications demonstrate how this compound contributes to addressing contemporary challenges in drug development and chemical biology research.

• 103877-78-7(5-Fluoro-4-methyl-2-nitrobenzoic Acid)
• 1261954-79-3(2-nitro-4-(2,4,6-trifluorophenyl)benzoic Acid)
• 1261904-25-9(4-(4-Carboxy-3-fluorophenyl)-2-nitrobenzoic acid)
• 1261890-95-2(3-(2,3-Difluorophenyl)-5-nitrobenzoic acid)
• 1261902-71-9(4-(2-Fluoro-4-methylphenyl)-2-nitrobenzoic acid)
• 1261902-88-8(4-(2-Fluoro-5-methylphenyl)-2-nitrobenzoic acid)
• 1261904-61-3(4-(5-Carboxy-2-fluorophenyl)-2-nitrobenzoic acid)
• 887244-17-9(4-(3-fluorophenyl)-2-nitrobenzoic acid)
• 669002-37-3(4-(4-Fluorophenyl)-2-nitrobenzoic acid)
• 1214359-91-7(4-(2-fluorophenyl)-2-nitrobenzoic Acid)